{
 "PrintNo":"A576","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2020-12-29T14:07:44.798974Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-01-06","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":520,"Name":"Linda Rosenthal","Short":"ROSENTHAL L"}],
 "Title":"Requires certain eligible persons or entities to acquire and possess opioid antagonists",
 "Summary":"Requires certain eligible persons or entities to acquire and possess opioid antagonists for emergency treatment of a person appearing to experience an opioid-related overdose.",
 "LawSection":"Public Health Law","LawCode":"Add ยง3000-e, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to requiring certain eligible persons or entities to acquire and possess opioid antagonists",
 "PreviousVersions":["A10187-2017","A448-2019"]
}